Skip to main content
Erschienen in: Surgical Endoscopy 1/2018

29.06.2017

Diagnostic staging laparoscopy in gastric cancer: a prospective cohort at a cancer institute in Japan

verfasst von: Tomoyuki Irino, Takeshi Sano, Naoki Hiki, Manabu Ohashi, Souya Nunobe, Koshi Kumagai, Satoshi Ida, Toshiharu Yamaguchi

Erschienen in: Surgical Endoscopy | Ausgabe 1/2018

Einloggen, um Zugang zu erhalten

Abstract

Background

There have been many studies that describe the value of diagnostic staging laparoscopy (DSL) in gastric cancer. However, different studies use different indications, making study results difficult to compare. This study aimed to clarify the diagnostic feasibility of DSL for gastric cancer in a prospective manner and investigated the impact of DSL on clinical decision-making in gastric cancer treatment.

Methods

The study was a prospective cohort study based at a single institution between January 2010 and December 2013. We treated 2213 patients with potentially resectable gastric cancer during this period. DSL was primarily indicated for asymptomatic patients with: (1) large Borrmann type 3 tumours ≥8 cm, (2) Borrmann type 4 tumours (linitis plastica), (3) bulky lymph nodes or paraaortic lymph node swelling, or (4) clinical suspicion of peritoneal disease. The primary outcome is change in treatment strategy, and the secondary outcomes are diagnostic accuracy of the indications and false negative rate of DSL.

Results

DSL was performed on 156 (7%) of 2213 patients. Of these, peritoneal disease was found in 74 (47%) patients: (1) 56% for large type 3, (2) 54% for type 4, (3) 21% for bulky lymph nodes or paraaortic lymph node swelling, and (4) 20% for suspected peritoneal disease. The diagnostic accuracy of our indication for DSL was 92% for all patients and 74% for patients with cT3/T4 tumours. Among 82 patients without peritoneal disease, 66 patients (81%) underwent subsequent radical gastrectomy; peritoneal disease was discovered intraoperatively for 7 patients at laparotomy, indicating a false negative rate of 11%.

Conclusion

We confirmed that DSL performed according to our indication, in the context of gastric cancer, possesses diagnostic feasibility. Approximately half of the patients who underwent DSL consequently avoided unnecessary laparotomy and were able to receive appropriate alternative treatment.
Literatur
1.
Zurück zum Zitat Kim SJ, Kim HH, Kim YH, Hwang SH, Lee HS, Park do J, Kim SY, Lee KH (2009) Peritoneal metastasis: detection with 16- or 64-detector row CT in patients undergoing surgery for gastric cancer. Radiology 253(2):407–415. doi:10.1148/radiol.2532082272 CrossRefPubMed Kim SJ, Kim HH, Kim YH, Hwang SH, Lee HS, Park do J, Kim SY, Lee KH (2009) Peritoneal metastasis: detection with 16- or 64-detector row CT in patients undergoing surgery for gastric cancer. Radiology 253(2):407–415. doi:10.​1148/​radiol.​2532082272 CrossRefPubMed
2.
Zurück zum Zitat Smyth E, Schoder H, Strong VE, Capanu M, Kelsen DP, Coit DG, Shah MA (2012) A prospective evaluation of the utility of 2-deoxy-2-[(18) F]fluoro-d-glucose positron emission tomography and computed tomography in staging locally advanced gastric cancer. Cancer 118(22):5481–5488. doi:10.1002/cncr.27550 CrossRefPubMed Smyth E, Schoder H, Strong VE, Capanu M, Kelsen DP, Coit DG, Shah MA (2012) A prospective evaluation of the utility of 2-deoxy-2-[(18) F]fluoro-d-glucose positron emission tomography and computed tomography in staging locally advanced gastric cancer. Cancer 118(22):5481–5488. doi:10.​1002/​cncr.​27550 CrossRefPubMed
3.
Zurück zum Zitat Leake PA, Cardoso R, Seevaratnam R, Lourenco L, Helyer L, Mahar A, Law C, Coburn NG (2012) A systematic review of the accuracy and indications for diagnostic laparoscopy prior to curative-intent resection of gastric cancer. Gastric Cancer 15(Suppl 1):S38–47. doi:10.1007/s10120-011-0047-z CrossRefPubMed Leake PA, Cardoso R, Seevaratnam R, Lourenco L, Helyer L, Mahar A, Law C, Coburn NG (2012) A systematic review of the accuracy and indications for diagnostic laparoscopy prior to curative-intent resection of gastric cancer. Gastric Cancer 15(Suppl 1):S38–47. doi:10.​1007/​s10120-011-0047-z CrossRefPubMed
4.
Zurück zum Zitat Roviaro GC, Varoli F, Sonnino D, Nucca O, Rabughino G, Scarduelli A (2000) Can routine laparoscopy help to reduce the rate of explorative laparotomies for gastric cancer? Laparoscopy in gastric cancer. Diagn Ther Endosc 6(3):125–131. doi:10.1155/DTE.6.125 CrossRefPubMedPubMedCentral Roviaro GC, Varoli F, Sonnino D, Nucca O, Rabughino G, Scarduelli A (2000) Can routine laparoscopy help to reduce the rate of explorative laparotomies for gastric cancer? Laparoscopy in gastric cancer. Diagn Ther Endosc 6(3):125–131. doi:10.​1155/​DTE.​6.​125 CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat Yano M, Tsujinaka T, Shiozaki H, Inoue M, Sekimoto M, Doki Y, Takiguchi S, Imamura H, Taniguchi M, Monden M (2000) Appraisal of treatment strategy by staging laparoscopy for locally advanced gastric cancer. World J Surg 24(9):1130–1135; discussion 1135–1136 Yano M, Tsujinaka T, Shiozaki H, Inoue M, Sekimoto M, Doki Y, Takiguchi S, Imamura H, Taniguchi M, Monden M (2000) Appraisal of treatment strategy by staging laparoscopy for locally advanced gastric cancer. World J Surg 24(9):1130–1135; discussion 1135–1136
8.
Zurück zum Zitat Katayama H, Ito S, Sano T, Takahari D, Mizusawa J, Boku N, Tsuburaya A, Terashima M, Sasako M (2012) A phase II study of systemic chemotherapy with docetaxel, cisplatin, and S-1 (DCS) followed by surgery in gastric cancer patients with extensive lymph node metastasis: Japan Clinical Oncology Group study JCOG1002. Jpn J Clin Oncol 42(6):556–559. doi:10.1093/jjco/hys054 CrossRefPubMed Katayama H, Ito S, Sano T, Takahari D, Mizusawa J, Boku N, Tsuburaya A, Terashima M, Sasako M (2012) A phase II study of systemic chemotherapy with docetaxel, cisplatin, and S-1 (DCS) followed by surgery in gastric cancer patients with extensive lymph node metastasis: Japan Clinical Oncology Group study JCOG1002. Jpn J Clin Oncol 42(6):556–559. doi:10.​1093/​jjco/​hys054 CrossRefPubMed
9.
Zurück zum Zitat Iwasaki Y, Sasako M, Yamamoto S, Nakamura K, Sano T, Katai H, Tsujinaka T, Nashimoto A, Fukushima N, Tsuburaya A (2013) Phase II study of preoperative chemotherapy with S-1 and cisplatin followed by gastrectomy for clinically resectable type 4 and large type 3 gastric cancers (JCOG0210). J Surg Oncol 107(7):741–745. doi:10.1002/jso.23301 CrossRefPubMed Iwasaki Y, Sasako M, Yamamoto S, Nakamura K, Sano T, Katai H, Tsujinaka T, Nashimoto A, Fukushima N, Tsuburaya A (2013) Phase II study of preoperative chemotherapy with S-1 and cisplatin followed by gastrectomy for clinically resectable type 4 and large type 3 gastric cancers (JCOG0210). J Surg Oncol 107(7):741–745. doi:10.​1002/​jso.​23301 CrossRefPubMed
11.
Zurück zum Zitat Nassour I, Fullington H, Hyman L, Yopp A, Augustine M, Polanco P, Choti M, Mansour J, Wang S, Porembka M (2017) The yield of staging laparoscopy in gastric cancer is affected by racial and ethnic differences in disease presentation. Ann Surg Oncol. doi:10.1245/s10434-017-5805-7) PubMedCentral Nassour I, Fullington H, Hyman L, Yopp A, Augustine M, Polanco P, Choti M, Mansour J, Wang S, Porembka M (2017) The yield of staging laparoscopy in gastric cancer is affected by racial and ethnic differences in disease presentation. Ann Surg Oncol. doi:10.​1245/​s10434-017-5805-7) PubMedCentral
12.
Zurück zum Zitat Maehara Y, Oiwa H, Oda S, Sakaguchi Y, Endo K, Ohno S, Sugimachi K (1995) Surgical treatment and prognosis for patients with gastric cancer lesions larger than ten centimeters in size. Oncology 52(1):35–40CrossRefPubMed Maehara Y, Oiwa H, Oda S, Sakaguchi Y, Endo K, Ohno S, Sugimachi K (1995) Surgical treatment and prognosis for patients with gastric cancer lesions larger than ten centimeters in size. Oncology 52(1):35–40CrossRefPubMed
13.
Zurück zum Zitat Roviello F, Marrelli D, de Manzoni G, Morgagni P, Di Leo A, Saragoni L, De Stefano A (2003) Prospective study of peritoneal recurrence after curative surgery for gastric cancer. Br J Surg 90(9):1113–1119. doi:10.1002/bjs.4164 CrossRefPubMed Roviello F, Marrelli D, de Manzoni G, Morgagni P, Di Leo A, Saragoni L, De Stefano A (2003) Prospective study of peritoneal recurrence after curative surgery for gastric cancer. Br J Surg 90(9):1113–1119. doi:10.​1002/​bjs.​4164 CrossRefPubMed
14.
Zurück zum Zitat Maruyama K, Okabayashi K, Kinoshita T (1987) Progress in gastric cancer surgery in Japan and its limits of radicality. World J Surg 11(4):418–425CrossRefPubMed Maruyama K, Okabayashi K, Kinoshita T (1987) Progress in gastric cancer surgery in Japan and its limits of radicality. World J Surg 11(4):418–425CrossRefPubMed
16.
Zurück zum Zitat Tsuburaya A, Mizusawa J, Tanaka Y, Fukushima N, Nashimoto A, Sasako M (2014) Neoadjuvant chemotherapy with S-1 and cisplatin followed by D2 gastrectomy with para-aortic lymph node dissection for gastric cancer with extensive lymph node metastasis. Br J Surg 101(6):653–660. doi:10.1002/bjs.9484 CrossRefPubMed Tsuburaya A, Mizusawa J, Tanaka Y, Fukushima N, Nashimoto A, Sasako M (2014) Neoadjuvant chemotherapy with S-1 and cisplatin followed by D2 gastrectomy with para-aortic lymph node dissection for gastric cancer with extensive lymph node metastasis. Br J Surg 101(6):653–660. doi:10.​1002/​bjs.​9484 CrossRefPubMed
17.
18.
Zurück zum Zitat Hato S, Iwasaki Y, Mizusawa J, Terashima M, Katai H, Yoshikawa T, Ito S, Kaji M, Fujita J, Hirao M, Yamada M, Takagi M, Kaytayama H, Nalamura K, Sano T, Sasako M (2017) Effectiveness and limitations of staging laparoscopy for peritoneal metastases in advanced gastric cancer from the results of JCOG0501: a randomized trial of gastrectomy with or without neoadjuvant chemotherapy for type 4 or large type 3 gastric cancer. JCO. doi:10.1200/JCO.2017.35.4_suppl.9 Hato S, Iwasaki Y, Mizusawa J, Terashima M, Katai H, Yoshikawa T, Ito S, Kaji M, Fujita J, Hirao M, Yamada M, Takagi M, Kaytayama H, Nalamura K, Sano T, Sasako M (2017) Effectiveness and limitations of staging laparoscopy for peritoneal metastases in advanced gastric cancer from the results of JCOG0501: a randomized trial of gastrectomy with or without neoadjuvant chemotherapy for type 4 or large type 3 gastric cancer. JCO. doi:10.​1200/​JCO.​2017.​35.​4_​suppl.​9
19.
Zurück zum Zitat Cunningham D, Allum WH, Stenning SP, Thompson JN, Van de Velde CJ, Nicolson M, Scarffe JH, Lofts FJ, Falk SJ, Iveson TJ, Smith DB, Langley RE, Verma M, Weeden S, Chua YJ, Participants MT (2006) Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med 355(1):11–20. doi:10.1056/NEJMoa055531 CrossRefPubMed Cunningham D, Allum WH, Stenning SP, Thompson JN, Van de Velde CJ, Nicolson M, Scarffe JH, Lofts FJ, Falk SJ, Iveson TJ, Smith DB, Langley RE, Verma M, Weeden S, Chua YJ, Participants MT (2006) Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med 355(1):11–20. doi:10.​1056/​NEJMoa055531 CrossRefPubMed
21.
22.
Zurück zum Zitat Enestvedt CK, Mayo SC, Diggs BS, Mori M, Austin DA, Shipley DK, Sheppard BC, Billingsley KG (2008) Diagnostic laparoscopy for patients with potentially resectable pancreatic adenocarcinoma: is it cost-effective in the current era? J Gastrointest Surg 12(7):1177–1184. doi:10.1007/s11605-008-0514-y CrossRefPubMed Enestvedt CK, Mayo SC, Diggs BS, Mori M, Austin DA, Shipley DK, Sheppard BC, Billingsley KG (2008) Diagnostic laparoscopy for patients with potentially resectable pancreatic adenocarcinoma: is it cost-effective in the current era? J Gastrointest Surg 12(7):1177–1184. doi:10.​1007/​s11605-008-0514-y CrossRefPubMed
23.
Zurück zum Zitat Shimada H, Noie T, Ohashi M, Oba K, Takahashi Y (2014) Clinical significance of serum tumor markers for gastric cancer: a systematic review of literature by the Task Force of the Japanese Gastric Cancer Association. Gastric Cancer 17(1):26–33. doi:10.1007/s10120-013-0259-5 CrossRefPubMed Shimada H, Noie T, Ohashi M, Oba K, Takahashi Y (2014) Clinical significance of serum tumor markers for gastric cancer: a systematic review of literature by the Task Force of the Japanese Gastric Cancer Association. Gastric Cancer 17(1):26–33. doi:10.​1007/​s10120-013-0259-5 CrossRefPubMed
24.
Zurück zum Zitat Fujimura T, Kinami S, Ninomiya I, Kitagawa H, Fushida S, Nishimura G, Kayahara M, Shimizu K, Ohta T, Miwa K (2002) Diagnostic laparoscopy, serum CA125, and peritoneal metastasis in gastric cancer. Endoscopy 34(7):569–574. doi:10.1055/s-2002-33228 CrossRefPubMed Fujimura T, Kinami S, Ninomiya I, Kitagawa H, Fushida S, Nishimura G, Kayahara M, Shimizu K, Ohta T, Miwa K (2002) Diagnostic laparoscopy, serum CA125, and peritoneal metastasis in gastric cancer. Endoscopy 34(7):569–574. doi:10.​1055/​s-2002-33228 CrossRefPubMed
25.
Metadaten
Titel
Diagnostic staging laparoscopy in gastric cancer: a prospective cohort at a cancer institute in Japan
verfasst von
Tomoyuki Irino
Takeshi Sano
Naoki Hiki
Manabu Ohashi
Souya Nunobe
Koshi Kumagai
Satoshi Ida
Toshiharu Yamaguchi
Publikationsdatum
29.06.2017
Verlag
Springer US
Erschienen in
Surgical Endoscopy / Ausgabe 1/2018
Print ISSN: 0930-2794
Elektronische ISSN: 1432-2218
DOI
https://doi.org/10.1007/s00464-017-5673-z

Weitere Artikel der Ausgabe 1/2018

Surgical Endoscopy 1/2018 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.